Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market Size, Production, Sales, Average Product Price, Market Share, Import vs Export 

Rising Demand in the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market Driven by Cancer Diagnostics 

The Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market is experiencing accelerated growth, driven by a marked increase in gastrointestinal and pancreatic cancer incidence globally. For instance, pancreatic cancer alone accounted for more than 500,000 new cases in 2023, as reported by leading global health organizations. The steady increase in cancer prevalence, coupled with a growing emphasis on early diagnosis, has intensified the demand for minimally invasive and highly accurate diagnostic methods such as EUS-FNA. This has resulted in heightened procurement of fine needle aspiration devices and corresponding ultrasound systems across hospitals and specialized diagnostic centers. 

The utility of EUS-FNA lies in its ability to provide tissue diagnosis with minimal risk, especially in hard-to-access areas like the pancreas and mediastinum. Hospitals and diagnostic centers are increasingly adopting these devices, boosting the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market across North America, Europe, and Asia Pacific. 

Technological Innovations Elevating the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market Trajectory 

Innovation in device engineering has reshaped the performance capabilities of EUS-FNA tools, directly influencing the trajectory of the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market. Devices are now manufactured with advanced features including laser-etched echogenic markings for enhanced ultrasound visibility, ergonomic needle control systems, and variable gauge flexibility for sampling lesions of varying sizes. 

For example, newly introduced 25G and 22G fine needles offer an ideal combination of flexibility and durability, particularly for pancreatic lesion aspiration. Devices integrated with locking mechanisms and dual bevel designs have further improved sample quality and minimized the number of needle passes required. This optimization leads to faster diagnosis and reduced patient discomfort, making the technology increasingly preferred in clinical environments. Datavagyanik estimates that next-generation EUS-FNA needles accounted for nearly 42% of total market revenue in 2024, underlining their growing importance in clinical workflows. 

Expanded Clinical Indications Fueling the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market 

Beyond oncology, the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market is expanding due to an increase in indications for non-cancerous diseases. EUS-FNA is now widely employed in diagnosing gastrointestinal submucosal tumors, pancreatic cysts, lymphadenopathy, sarcoidosis, and autoimmune pancreatitis. For instance, the use of EUS-FNA in the diagnosis of pancreatic cystic neoplasms has grown by 18% year-over-year as more guidelines support its use for risk stratification. 

This broadening of application areas has not only increased the volume of procedures performed but also encouraged healthcare providers to invest in versatile and high-quality aspiration systems. Datavagyanik emphasizes that hospitals are increasingly incorporating EUS-FNA capabilities into their gastrointestinal endoscopy units as part of a broader trend toward multidisciplinary diagnostics. 

Growing Role of Ambulatory Surgical Centers in the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market 

Ambulatory surgical centers (ASCs) are playing a pivotal role in driving growth within the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market. The procedural shift from inpatient to outpatient settings has gained momentum due to healthcare cost containment pressures and improvements in endoscopic technology that allow for safe and rapid interventions. 

In the United States alone, more than 200,000 EUS-FNA procedures were performed in ASCs in 2023. This number is projected to rise at a CAGR of over 9% through 2027, as per Datavagyanik estimates. Factors such as reduced waiting times, lower procedural costs, and better reimbursement structures are enabling ASCs to emerge as a major channel for EUS-FNA procedures. Consequently, device manufacturers are now tailoring product lines to meet the workflow and equipment compatibility standards specific to these centers. 

Strategic Product Launches Reshaping the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market 

The competitive landscape of the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market is being reshaped by strategic product launches and innovation-driven partnerships. For example, Olympus introduced a novel EUS-FNA needle in 2024 that incorporates a proprietary side-port design for enhanced cellular yield. Simultaneously, Boston Scientific expanded its distribution footprint in Southeast Asia and Latin America to cater to rising demand in underserved regions. 

Such strategic actions are aimed at not only enhancing brand equity but also ensuring rapid market penetration in geographies experiencing high diagnostic procedure growth. Datavagyanik notes that over 35% of market revenue between 2023 and 2025 will be driven by innovative product offerings and expansion in fast-growing economies. 

Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market Size Influenced by Public and Private Healthcare Infrastructure Growth 

The Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market Size is directly influenced by advancements in healthcare infrastructure across both developed and emerging economies. Government-backed health insurance schemes, such as India’s Ayushman Bharat and Brazil’s SUS program, are encouraging greater access to diagnostic services including EUS-FNA. At the same time, private hospital chains are investing heavily in advanced endoscopic suites to accommodate rising demand. 

For instance, private hospitals in India and the Middle East expanded their endoscopic diagnostic capacity by over 20% in 2024, with EUS-FNA procedures forming a key component of this growth. These developments are creating sustained demand for both reusable and single-use aspiration needles, ultrasound probes, and ancillary accessories, contributing to the long-term expansion of the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market Size. 

Regulatory Landscape and Reimbursement Policies Impacting the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market 

The regulatory environment and reimbursement policies are shaping the direction of the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market. Favorable reimbursement frameworks in North America and Europe are encouraging widespread adoption of EUS-FNA procedures. For instance, the U.S. Centers for Medicare & Medicaid Services (CMS) increased coverage for outpatient diagnostic endoscopic services in 2023, making EUS-FNA a more accessible procedure for elderly populations. 

On the regulatory front, the shift towards harmonized medical device regulations, such as MDR in Europe and evolving FDA pathways in the U.S., is enhancing the approval speed for next-gen EUS-FNA tools. These streamlined pathways are incentivizing companies to fast-track innovation and commercialization, driving further competitiveness in the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market. 

 

“Track Country-wise Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Production and Demand through our Database”

• • • Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices sales volume database for 28+ countries worldwide

 

 

North America’s Leadership in the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market 

North America continues to dominate the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market, driven by robust healthcare infrastructure, widespread adoption of minimally invasive diagnostic procedures, and early adoption of advanced endoscopic technologies. For example, in 2024, the United States accounted for more than 38% of the global demand for EUS-FNA devices. This growth is strongly tied to increasing incidences of pancreatic, esophageal, and gastric cancers. Datavagyanik identifies that academic medical centers and high-volume cancer institutions across the U.S. performed over 350,000 EUS-FNA procedures in 2023, with an annual increase rate of 11%. 

The presence of major device manufacturers and favorable reimbursement structures further support market dominance in the region. Moreover, physician awareness and routine use of EUS-FNA as a standard diagnostic pathway contribute to consistent procedure volumes and recurring equipment purchases. 

Rapid Market Expansion in Asia Pacific Driving the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market 

Asia Pacific is emerging as the fastest-growing region in the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market. Countries such as China, India, Japan, and South Korea are seeing a rise in gastrointestinal and pancreatic disease prevalence. Datavagyanik notes that China’s demand for EUS-FNA devices surged by 17% in 2024, propelled by urban hospital upgrades and wider deployment of endoscopic services across tier-II and tier-III cities. 

For instance, India’s top private healthcare chains, including Fortis and Apollo, expanded their endoscopic diagnostic capacities by 25% last year, with a dedicated focus on training more gastroenterologists in EUS-FNA techniques. Government-led programs such as Ayushman Bharat and digital health initiatives have increased patient access to early diagnostics, which is fostering greater market penetration. 

Europe’s Steady Demand and Focus on Innovation in the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market 

The Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market in Europe is characterized by stable demand, supported by an aging population and structured cancer screening programs. Countries like Germany, France, and the UK are major contributors, with Germany alone representing 22% of Europe’s EUS-FNA device sales in 2024. Datavagyanik highlights the role of national health programs in encouraging early gastrointestinal cancer detection, thereby boosting procedural volumes. 

In addition to steady demand, Europe is also seeing an uptick in innovation-led procurement. Hospitals are shifting from reusable to semi-disposable EUS-FNA devices to minimize infection risk and streamline procedure efficiency. Several university hospitals are collaborating with medical device firms to pilot next-gen aspiration technologies, driving advanced usage patterns in the region. 

Latin America and the Middle East Showing Emerging Potential in the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market 

Emerging economies in Latin America and the Middle East are gradually contributing to the expansion of the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market. For instance, Brazil and Saudi Arabia have reported double-digit growth in EUS-FNA procedures over the past two years. Datavagyanik attributes this to increased government investments in oncology care and new hospital construction. 

In Brazil, federal funding for tertiary cancer centers resulted in a 20% increase in endoscopy unit installations in 2024, enabling a wider adoption of EUS-FNA. Similarly, Gulf countries have been importing advanced diagnostic technologies as part of their Vision 2030 healthcare agendas, leading to new procurement contracts for global and regional device manufacturers. 

Overview of Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Manufacturing Hubs 

The Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Manufacturing landscape is geographically diverse, with production facilities concentrated in North America, Japan, Germany, and increasingly in Southeast Asia. Leading players such as Olympus, Medtronic, and Cook Medical have production hubs in the United States and Japan, supplying high-precision FNA needles to global markets. These facilities emphasize quality control, R&D, and regulatory compliance. 

Datavagyanik notes that low-cost Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Manufacturing is gaining traction in countries like Malaysia and Vietnam, where favorable labor costs and export incentives are attracting medical device OEMs. Contract manufacturing partnerships have enabled scalability without compromising technical specifications, allowing companies to serve both premium and cost-sensitive segments globally. 

Strategic Outsourcing Trends in Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Manufacturing 

A rising trend within the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Manufacturing sector is strategic outsourcing. Companies are increasingly subcontracting component production and assembly to specialized vendors. For instance, critical components such as stainless-steel needles, control hubs, and plastic handle grips are now often sourced from precision engineering firms based in Taiwan and South Korea. 

This shift is helping manufacturers reduce overhead, shorten lead times, and streamline distribution. According to Datavagyanik, over 40% of global EUS-FNA needle volume in 2024 was manufactured through outsourced production models, signaling a deepening reliance on contract development and manufacturing organizations (CDMOs). 

Market Segmentation in the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market by Product Type 

The Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market is segmented by product type into aspiration needles, biopsy needles, needle-based confocal laser endomicroscopy systems, and supporting accessories. Aspiration needles account for the highest market share due to their widespread use in pancreatic, mediastinal, and hepatic lesion sampling. For example, 22G and 25G needles are preferred for soft tissue targeting in over 65% of EUS-FNA procedures globally. 

Datavagyanik observes growing interest in fine needle biopsy (FNB) devices that offer core tissue sampling capabilities. These devices are especially useful in immunohistochemical analysis and molecular profiling of tumors, allowing for more accurate diagnosis and treatment planning. The segment is expected to grow at over 14% CAGR through 2027. 

Segmentation of the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market by End User 

End users in the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market include hospitals, ambulatory surgical centers, and diagnostic laboratories. Hospitals represent the largest user base, particularly tertiary and quaternary care institutions. They possess the infrastructure, physician expertise, and patient volumes necessary for routine EUS-FNA procedures. 

Ambulatory surgical centers are the fastest-growing segment, registering a 12% annual growth rate as of 2024. Their growth is supported by rising patient preference for outpatient diagnostics and cost-effective care. Meanwhile, diagnostic laboratories are forming partnerships with GI clinics and hospitals to offer mobile or on-site EUS-FNA services, further diversifying the market’s end-user landscape. 

Pricing Dynamics and Trends in the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market 

The Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market exhibits moderate pricing variability based on device configuration, material grade, and geographic region. Premium aspiration needles used in advanced cancer centers typically range between USD 100 to USD 200 per unit, depending on customization. In contrast, lower-cost options designed for high-volume clinics in emerging markets may fall within the USD 50 to USD 80 range. 

Datavagyanik points out that average selling prices have remained relatively stable in developed markets, while in price-sensitive regions such as Africa and South Asia, competitive pricing from regional manufacturers has led to a 10–15% price reduction over the past two years. Additionally, the shift from reusable to single-use devices in infection-sensitive environments is gradually increasing the per-procedure cost, which in turn is influencing procurement strategies across hospitals. 

Influence of Reimbursement and Procurement Models on the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market 

Procurement strategies in the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market are increasingly shaped by bundled reimbursement models and public-private partnerships. In countries such as the United States, reimbursement is tied to diagnostic accuracy and procedural efficiency, favoring premium, high-yield needles. Group purchasing organizations (GPOs) are also negotiating volume-based discounts for hospital networks, which impact pricing tiers and brand penetration. 

Emerging economies are seeing procurement through national tenders and global health alliances. For example, public hospitals in Africa and Southeast Asia have received grants to equip cancer diagnostic units with EUS-FNA capabilities, creating long-term demand pipelines. Datavagyanik anticipates that by 2026, value-based procurement will dominate over 60% of device purchases in high-income nations. 

“Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Manufacturing Database”

• • Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices top manufacturers market share for 28+ manufacturers
  • Top 8 manufacturers and top 18 manufacturers of Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices in North America, Europe, Asia Pacific
  • Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices sales dashboard, Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices sales data in excel format

 

Leading Players in the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market 

The Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market is dominated by a small group of global manufacturers that have established strong brand portfolios, wide distribution networks, and extensive clinical acceptance. These companies invest significantly in product development, physician training programs, and market expansion, enabling them to capture significant share in both developed and emerging regions. 

Some of the leading manufacturers in the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market include Olympus Corporation, Boston Scientific Corporation, Medtronic plc, Cook Medical, CONMED Corporation, Medi-Globe GmbH, and ACE Medical Devices. Each of these players offers differentiated product lines targeting specific anatomical and procedural needs in EUS-guided aspiration and biopsy. 

Olympus Corporation: Market Leader in Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market 

Olympus Corporation holds a leading position in the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market, with an estimated global market share of around 28% as of 2024. The company’s product line includes the EZ Shot 3 Plus series, which is designed for optimal flexibility, improved puncture control, and enhanced visualization under ultrasound. These needles are available in multiple gauge sizes, catering to a wide spectrum of endoscopic applications. 

Olympus maintains strong brand credibility in Japan, Europe, and North America and continues to expand its product reach in Asia-Pacific through channel partnerships and endoscopy center collaborations. Its emphasis on quality, ergonomic designs, and physician training has been a key driver of its market dominance. 

Boston Scientific: Innovation-Driven Growth in Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market 

Boston Scientific has secured a notable 23% share in the global Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market. The company’s Acquire Endoscopic Ultrasound Fine Needle Biopsy Device is widely adopted in academic and clinical settings due to its tri-heel tip design, which allows for superior tissue acquisition and minimal trauma. Boston Scientific’s emphasis on biopsy-quality tissue collection has positioned it favorably in oncology-focused hospitals and centers of excellence. 

Its strategic investments in physician education and clinical trials further reinforce product efficacy and strengthen adoption. Boston Scientific also benefits from a diversified gastrointestinal device portfolio, enabling bundled procurement across endoscopy units. 

Cook Medical: Trusted Legacy Brand in the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market 

Cook Medical is known for its legacy in interventional diagnostics and holds around 16% of the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market. Its EchoTip Ultra and EchoTip ProCore needles have earned widespread recognition for precise echogenic markings, tip durability, and compatibility with various echoendoscopes. EchoTip ProCore, in particular, is used extensively in fine needle biopsy procedures requiring high-quality histological samples. 

Cook Medical’s long-standing relationships with leading GI hospitals, coupled with its consistent product innovation and distribution efficiency, make it a reliable player across North America, Europe, and selected Asia-Pacific markets. 

Medtronic: Expanding Presence in the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market 

Medtronic continues to strengthen its position in the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market, holding an estimated 12% global share. Its SharkCore FNB needle has been designed for single-pass core tissue collection and is gaining traction among clinicians who prioritize rapid diagnostic workflows. The company is investing in expanding its footprint in emerging markets through local partnerships and digital sales channels. 

Medtronic’s ability to cross-leverage its brand equity in surgical and imaging technologies has enabled it to penetrate new hospital accounts and reinforce its role in integrated care pathways. 

Medi-Globe and ACE Medical Devices: Growing Mid-Tier Competitors in Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market 

Medi-Globe GmbH and ACE Medical Devices are emerging as strong mid-tier players in the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market, with combined market share estimated at 8–10%. Medi-Globe’s SonoTip Pro Control line offers precision-engineered aspiration needles with robust handle control and visibility enhancements. The brand has gained traction in several European countries and is expanding its reach in Latin America. 

ACE Medical Devices, based in India, is capturing demand in price-sensitive markets with its cost-effective disposable needle lines. The company focuses on high-volume tenders and secondary care hospital sales, contributing to broader access in underserved regions. 

Market Share Distribution and Competitive Dynamics in the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market 

The Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market remains moderately consolidated, with the top five players accounting for over 75% of global revenues. Market competition is centered around innovation, pricing flexibility, clinical outcomes, and endoscopist preference. As newer biopsy-capable needles enter the market and manufacturers continue to refine needle tip geometry and ergonomic features, product differentiation is expected to intensify. 

Datavagyanik anticipates increased competition in the mid-tier segment, especially as regional manufacturers scale up production and pursue regulatory approvals in Europe and North America. Strategic alliances between device firms and healthcare providers are also reshaping the procurement landscape. 

Recent Developments in the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market 

Several important developments have occurred in the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market over the past 12 to 18 months, reflecting a high level of innovation and strategic repositioning: 

• In March 2024, Olympus launched an advanced version of the EZ Shot 3 Plus featuring a dual-layer sheath designed to minimize friction during scope angulation. The update is intended to support improved maneuverability in tortuous anatomies. 

• In June 2024, Boston Scientific expanded its Acquire needle product line with additional gauge sizes, aiming to improve flexibility in small lesion targeting while maintaining tissue integrity. 

• In September 2024, Cook Medical announced its plans to establish a needle-focused manufacturing facility in Ireland to support European market growth and mitigate supply chain dependencies. 

• In January 2025, Medtronic reported its SharkCore needle was selected as part of a bundled supply agreement with a leading U.S.-based cancer center network, signaling growing preference for biopsy-optimized EUS tools. 

• In February 2025, ACE Medical Devices introduced its latest disposable needle range at the India MedTech Expo, showcasing affordable devices for high-volume regional hospitals and public health systems. 

These strategic moves reflect a continued focus on improving device design, expanding market access, and responding to clinician feedback. The evolving dynamics of the Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market suggest that manufacturers are increasingly aligning their offerings with procedure-specific demands and regional clinical needs. 

 

“Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Production Data and Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Production Trend”

• • • Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices sales database for historical years, 10 years historical data
    • Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices sales data and forecast for next 7 years